Skip to content

Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study

Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084439
Enrollment
Unknown
Registered
2024-05-16
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

1:Use 0.05% atropine eyedrop daily and low-level red light therapy for 3 minutes twice per school day at home with an interval of at least 4 hours
2:Use 0.025% atropine eyedrop daily and low-level red light therapy for 3 minutes twice per school day at home with an interval of at least 4 hours
3:Use 0.01% atropine eyedrop daily and low-level red light therapy for 3 minutes twice per school day at home with an interval of at least 4 hours
4:Receive the placebo eyedrop once daily and sham red light device for 3 minutes twice per school day at home with an interval of at least 4 hours

Sponsors

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: - Age 4 to 12 - Myopia: SE equal or less than -1.0 D - Astigmatism: < 2.5 D - Anisometropia: < 2.0 D - Informed parental consent

Exclusion criteria

Exclusion criteria: - Ophthalmic diseases other than refractive errors - Previous use of treatment of atropine, RLRL, or other optical myopia control methods (e.g. defocusing lenses or contact lenses, orthokeratology) - Allergy or intolerance to atropine or RLRL - Inability to attend regular follow up assessment

Design outcomes

Primary

MeasureTime frame
Changes in SER;Changes in axial length;

Secondary

MeasureTime frame
Changes in pupil size, accommodation, and visual acuity;

Countries

China

Contacts

Public ContactDr YAM Cheuk Sing Jason

Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong

yamcheuksing@cuhk.edu.hk+852 3943 5892

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026